{"name":"Kadimastem","slug":"kadimastem","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNMXNEcVRQRlF1RGVzVnZOVzhpV01tRTI5U3BxNlNYaW53NFFmZDR0cG1haXNLbTAyUTA3RHdleWlPeGU4NHE3WjFndFJPYXNhUTVFT1o3aVl6T050NXFHVXBtdEQxMFVlMndlRGc3MTIway1VMlRNN2tuVDhMOUlSMEMtMUJ2SWRaZERJbTV5WENzVFEwS3lJ?oc=5","date":"2025-11-04","type":"pipeline","source":"Startupticker.ch","summary":"NLS Pharma and Kadimastem finalise business combination - Startupticker.ch","headline":"NLS Pharma and Kadimastem finalise business combination","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxPcUFLMlJjb1E4UlhuWkV2TzkyMWFma1BOZlRuQUNJYjBtQjJnOS1MajN2REVGRnVUSExhbUlqMHM4MERBQ3pEbGdNeEJnZVJYNVZONDZPeU9WcFhQdng1OEM5MEUxb3l1am4zUGxBcG02QllFazFxb09YUmRnOTR3c1RMcFdWRW5aWWNwcll0Ql91eGphX1Q0ekpfMUdDNEFNdjNLcWhmbjByeV9LMWgwelJqTkRJWks1MHFxalQxYkFYTjBBbW5scm0wY04xLWpoM1NkSjlfeEJQY2wtM1NhNXFtdVF2ZHZIZVhPRjU2aEVOME5kR183TE5VOE9PeVpOajBvaWhfWExSR1NGc2V1V1ZKMVp2SzJvT2doUG9Sb3FIVURwNjFWclNVOFB4Zw?oc=5","date":"2025-10-29","type":"deal","source":"PR Newswire","summary":"NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares - PR Newswire","headline":"NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOY2I1ZDR4N2M1VnZEWFAxOWRMMXdIbEJyZnFvZ29kekJ3akZsYWR5bHB0R2dXTzVfV1cya3JKUVR5NDM0ZmdfRUxWTG9weURuNnp4MTBCb19SZFJIVTd0S2std21heGx4dkg1aFgwVEVJMDVxZjQ3RWM5ZHpHWkVZVnk1U2dfbXo4QUpNM0J3dkhrcmttLU1wdE1vWUFFOGQ3TTFzSUZJNEVNc0M5THpxN1QtQjI3WjNOUjNWVVY2YW8wcGJHa0p0NXhrMlZNQmVGOTFLNDNBMEZWR0Z1NWdqQVR0Zm9Lc09NazlWSXB3VW5RUDBPcWhGa0VQaFBncHU2VVh0bUQxZTlCWGVPaDEtQw?oc=5","date":"2025-10-29","type":"deal","source":"PR Newswire","summary":"NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem - PR Newswire","headline":"NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Ka","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxOZ0Fkd241TDFGTGthbG1rWkFfY0RteG5fRHpEdGxRSGVmX0tPVTNpR0FqYlhhOFJFN3JGQlpwTVJ3UlVVek1MRUtEVER1a1VsMFB5V25rOGtIRnhNNm5TYXdjbkVXQjlHMS03ckpLeUxFb29aLXo3OFdjSkNZTVprSmFCUS05amlmcGlGd2pQWXVtVV9RdnlMSy0zeWdCWXRqNGY1OVJPbnZiX1F4dUdzaGo3YUhhRElSVmgtZmRIaHNkWmEtRDRXWTZ5NDFZRF93VUxCdnRENDM1X3F3bjNTNElnNDZaS3AyTGpFeVhnVW9yRTFYS0NLb0MwWmwxNFZzcWNOb3MxandXcldHZ20tQm8xLVJFVDBOVU1jMEh0ckFGNnRzRTJUSU9acTlRa1pMZXI4?oc=5","date":"2025-10-27","type":"deal","source":"PR Newswire","summary":"NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies - PR Newswire","headline":"NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Gene","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOYlNmY2I0eVVQY1YzRGE0TVhSRHVkZmdvRXhOQzBTUmpEWUM4Wk5CU3RKUkExYTRGZzltdVU5U0xKaTd1OFNtaHkzLTZ6RUJLUDR4TEZhYW5IckJHWmFaS3RDaVJqNWZvV096b2dVVTVOV09oUURpakpiVTROd2N2Nnlqc0J2cVFxQkc1cjhrZlAzSU5lejNhMXVPQkRvbl8xeFdlb3ZKWkplUEE5bTBUazZEWkhCdFg0VzIzeUE0TnVuRmx5bC13Y2ZjUHBrUUdSeXFLRmIxTHV0M1Q1bjA0dE1Uc0Z6dk1GY2c?oc=5","date":"2025-10-23","type":"regulatory","source":"PR Newswire","summary":"NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 - PR Newswire","headline":"NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOMW16Vk1CaWJjNXJrRUd2MDcydGNZVjdaTFBoTkJURmdmaHd2cmM5NUVvRC1HQUtaMjV0QUxwSi13bnEtXzd4YWEwOWQxNDVRbkFzdUtHc1YyWFZiOUQweEZ1c2s3RndkMEh5aWFMeWkyc3pZTDhtYnJJOW5ockludU5PWThoeWpKaEdqS3IxWGFJcFNudFM4ZlhJbWFUM1ZtTW9HUWplemdTVnh3VEtCcG0yVVcwMHNQUGF3VHczVnd5ZEZYdmJCNXlfTU9kQThtLUttX25TRlNqX3Zuc3AtLTBKdHRLTGRsV1pOU2pBeU8wQjhFMkZOek9BYmFmUUxhdlE?oc=5","date":"2025-09-30","type":"regulatory","source":"PR Newswire","summary":"NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting - PR Newswire","headline":"NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQZzVGdE5BVFJPY0dmODJQUkNNMFhZMDFWVVYtNnczNnQyRGlQS0FBUDE1b3pWdzFQVHVCZ1huWmlzQmk2M2lHeTBiQTBMMEZNdnVyNUsxX0ctQ3hJVlBDU1J2RUFkOFdrdUlqbVdEVXQyOHNQeGJkNTFvQXlJdGpNdFdUcnFaWGppcncxUk9fRkxmSFFNc19LY2MwUEpleDczU1VkSXpxX0R4dnk0MXBsaGJUZVA3dFluSHUwN0dEdTNfUTZ4clZuYmRabGZ2QmFZOUMySl9PaFZYaGpmVzBqRHd0WUowaWM3bWhabmpTNUF6ZWJILWFBUERaUjlUdWNsTHFMbFY0aw?oc=5","date":"2025-09-10","type":"deal","source":"PR Newswire","summary":"Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger - PR Newswire","headline":"Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOWU85NGVyOFoyeHN5dnVtUWlIb2Z3MjFubTJlQTVEcXhKUmtvb0ljNzQ5dGhIZHVCei1jc1RFcV82anduWl9rckZMOXAxZ05YUENmdXNUT0VlN0t6N0tlemlKZWpMWlczdDNQTXZ2U050SDh4cWxXNVhJYU1zM2p2eDRQbEswbEpidG5HZ0dGRjJKZTNLdzF6di0za2hUMWNfZ2ZTX2h1SXRCdWhOSW5reVhSaFc5UTRMOThWaTBFbw?oc=5","date":"2025-01-31","type":"regulatory","source":"PR Newswire","summary":"Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics - PR Newswire","headline":"Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNNkt1bWpTNTFkOUlGbkhfTnJjajdRYV9QRkVBUTdzUUE2eGxhMFNfSnVfUEhxWC1FS0RnM29HZzBZS0hOWGRwQzI1X1I3UkpJemp0YVVtdGZVck5SelMxYURlZGFEX1g1ZUtsQjU3RXJpNnZJWEVpLU1MZUNwRFNJUVoyaTk5X0xYMWJhNy1ZSlRwZDU0dWRINlBLZkVGRzJVYnJvZzdUTm5iRTla?oc=5","date":"2024-07-18","type":"pipeline","source":"Contract Pharma","summary":"Pluri’s CDMO to Manufacture Kadimastem’s Cell Therapy Candidates - Contract Pharma","headline":"Pluri’s CDMO to Manufacture Kadimastem’s Cell Therapy Candidates","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":9,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}